Publication | Closed Access
Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
21
Citations
59
References
2020
Year
MedicineNeuropharmacology6-Ohda-lesioned Rat ModelNeurologyNeuroscienceL-dopa-induced DyskinesiaDopaminePharmacology
| Year | Citations | |
|---|---|---|
Page 1
Page 1